TP53 and breast cancer: The incidence and mortality of bladder cancer have been increasing annually.[1] Although the identification of gene mutations, such as FGFR3[2] and p53,[3] and chromosome alterations[4] in BC specimens has shed light on BC development, a specific targeted therapy is still lacking.